The IPO SPAC-Tacle

Episode Summary

Executive Summary: The episode examines the 2020-21 IPO boom, contrasting today’s strong public markets with pandemic-era economic weakness and asking whether high valuations signal a bubble. Guests Jay Ritter and David Ludwig say fundamentals and lower rates support the IPO market, while Stanford’s Michael Klausner argues SPACs are structurally dilutive and likely overextended. The discussion concludes that traditional IPOs remain dominant, but SPACs and direct listings are reshaping how companies go public.

Main Topics: 2020-21 IPO Boom in Context (Priority: 5/5): The episode frames the surge in IPO activity against a pandemic shock that briefly shut markets, then reopened with unprecedented strength, especially in the U.S. Why Companies Stayed Private Longer (Priority: 4/5): Ritter explains that after the dot-com crash, fewer young companies went public and many instead relied on venture capital or sold to larger tech firms. Valuations and Bubble Concerns (Priority: 5/5): The conversation assesses whether rich valuations in tech and biotech resemble the late-1990s bubble, with guests citing both elevated multiples and strong fundamentals. SPACs as a Major Force in Public Listings (Priority: 5/5): SPACs are presented as a defining feature of the current cycle, with discussion of their benefits, trade-offs, and rapid growth in 2020 and early 2021. Differences Between IPOs, Direct Listings, and SPACs (Priority: 4/5): Ludwig outlines how each listing method serves different company objectives, with traditional IPOs still offering the most control and being the most popular. Structural Critique of SPACs (Priority: 5/5): Klausner argues SPACs embed substantial dilution through sponsor promote, warrants, underwriting costs, and redemptions, making them unattractive for post-merger shareholders. Outlook and Risks to the Market (Priority: 4/5): The guests identify risks such as rising rates, vaccine setbacks, deteriorating deal quality, or sharp equity market declines that could slow or reverse issuance.

Key Arguments: The current IPO surge is strong by modern standards, though not necessarily unprecedented if SPACs are excluded; it looks very different from the 1990s when more operating companies went public. A major long-term change is that young tech companies now stay private much longer after the dot-com crash, financed by venture capital and often acquired instead of IPO-ing. High valuations can be justified partly by low interest rates and the success of earlier high-multiple tech IPOs that ultimately grew into dominant firms. The market environment is unusually supportive because equity investors are optimistic even though the broader economy remains under pressure from the pandemic. Traditional IPOs remain the default choice because they offer more control and are well understood, but direct listings and SPACs are gaining share as alternative routes to market. SPACs can be attractive to pre-merger investors because they function like a relatively low-risk, default-free convertible instrument, but post-merger returns have often been weak. Klausner’s core critique is that SPACs create a structural 'hole' from dilution and redemption mechanics, which harms the quality of capital entering the operating company. Even if some recent SPAC deals perform well, the scale of dilution means the structure is not sustainable in its current form, in Klausner’s view.

Data Points: Global IPO issuance in 2020: more than $300 billion - Total worldwide IPO proceeds during the year described as a boom period. U.S. IPO issuance in 2020: $170 billion - Record U.S. proceeds cited as evidence of the market rebound. U.S. operating-company IPOs in 2020: 165 - Jay Ritter’s count of operating companies going public, excluding SPACs and ADRs. U.S. SPAC IPOs in 2020: 248 - Ritter’s count of SPAC listings in a year when SPACs dominated issuance. Share of U.S. IPOs that were SPACs in 2020: more than 50% - SPACs accounted for the majority of U.S. IPO volume. Biotech IPOs in 2020: 77 - Ritter says biotech was the industry with the highest number of IPOs. Median tech IPO price-to-sales ratio in a typical year over the last 20 years: about 6 - Baseline valuation level described by Ritter. Median tech IPO price-to-sales ratio in 2018-2019: 10-11 - Valuations rose sharply before 2020. Median tech IPO price-to-sales ratio in 2020: about 24 - Ritter says the median tech IPO valued at roughly twice the 2018-19 level. 30-year TIPS yield during the internet bubble: about 400 bps plus inflation - Ritter compares historical interest-rate conditions to today. 30-year TIPS yield today: about -30 bps - Lower real rates help justify higher equity multiples. Average SPAC IPO investor return: 9.3% per year - Ritter describes pre-merger SPAC investing as an attractive default-free-like trade. SPAC unit offer price: $10 per unit - Typical IPO pricing for SPAC vehicles. Typical SPAC IPO size: about $200 million - Ritter’s description of a standard SPAC raise. Typical sponsor promote: 20% of post-IPO equity - One of the key dilution sources Klausner identifies. Median cash per $10 share in SPAC mergers studied: $6.60 - Klausner’s study of 47 SPAC mergers in 2019 and H1 2020. Range of redemption rates in Klausner’s data: 0% to 98% - Shows extreme variability in SPAC dilution and cash delivered to the target. SPAC IPOs in the first week of January 2021: 28 deals - Ritter cites this as the strongest week ever for SPAC launches. SPAC IPO price jump in early January 2021: more than 5% on average - Indicative of intense investor demand for SPAC units. Average SPAC IPO price jump in 2020: 1.6% - Compared to 0.6% before 2020, showing increased demand. Average pre-2020 SPAC IPO price jump: 0.6% - Historical baseline for SPAC trading above issue price.

Pivotal Quotes: "The market's confidence in the success of vaccination, a low-rate environment, and fiscal stimulus have enabled the financing markets to be in much better shape than the overall economy." — David Ludwig: Explaining why IPO conditions are strong despite pandemic-related economic stress. "People have talked about comparisons to the tech bubble of the late 90s. Are you in agreement with that? The valuations are high on many of the companies." — Jay Ritter: Discussing whether current IPO valuations resemble the dot-com bubble. "I have never heard a good answer to that question." — Michael Klausner: Reacting to why SPACs collect cash from one investor base and then transfer it to another through a merger structure.

Implications: The IPO market appears durable, but investors should distinguish strong operating companies from hype. Traditional IPOs likely stay central, while SPACs may face pressure for reform if dilution and weak post-merger returns persist.